Tracing COVID-19 Source of Infection Among Health Personnel in a Pediatric Hospital.
COVID-19
SARS-CoV-2
community transmission
health personnel
hospital transmission
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2022
2022
Historique:
received:
15
03
2022
accepted:
02
05
2022
entrez:
27
6
2022
pubmed:
28
6
2022
medline:
28
6
2022
Statut:
epublish
Résumé
Health personnel (HP) have been universally recognized as especially susceptible to COVID-19. In Mexico, our home country, HP has one of the highest death rates from the disease. From the beginning of the SARS-CoV-2 pandemic, an office for initial attention for HP and a call center were established at a COVID-19 national reference pediatric hospital, aimed at early detection of COVID-19 cases and stopping local transmission. The detection and call center implementation and operation, and tracing methodology are described here. A total of 1,042 HP were evaluated, with 221 positive cases identified (7.7% of all HP currently working and 26% of the HP tested). Community contagion was most prevalent (46%), followed by other HP (27%), household (14%), and hospitalized patients (13%). Clusters and contact network analysis are discussed. This is one of the first reports that address the details of the implementation process of contact tracing in a pediatric hospital from the perspective of a hybrid hospital with COVID-19 and non-COVID-19 areas.
Identifiants
pubmed: 35757120
doi: 10.3389/fped.2022.897113
pmc: PMC9218243
doi:
Types de publication
Journal Article
Langues
eng
Pagination
897113Informations de copyright
Copyright © 2022 de la Rosa-Zamboni, Ortega-Riosvelasco, González-García, Gamiño-Arroyo, Espinosa-González, Valladares-Wagner, Saldívar-Flores, Aguilar-Guzmán, Sanchez-Pujol, López-Martínez, Villa-Guillén, Parra-Ortega, Jamaica-Balderas, Sienra-Monge and Guerrero-Díaz.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Lancet Infect Dis. 2021 Mar;21(3):298-299
pubmed: 33306982
Lancet Infect Dis. 2020 Dec;20(12):1401-1408
pubmed: 32758438
Am J Epidemiol. 2021 Jan 4;190(1):161-175
pubmed: 32870978
PLoS One. 2020 Dec 4;15(12):e0242589
pubmed: 33275599
Clin Infect Dis. 2021 Jul 1;73(1):e191-e198
pubmed: 32986819
Med Leg J. 2020 Jul;88(2):65-66
pubmed: 32441196
Int J Infect Dis. 2021 Jan;102:32-36
pubmed: 33039607
Clin Infect Dis. 2021 Jul 1;73(1):e199-e205
pubmed: 32986118
Emerg Infect Dis. 2020 Oct;26(10):2465-2468
pubmed: 32673193
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Bol Med Hosp Infant Mex. 2020 Nov 23;78(1):3-9
pubmed: 33226975
F1000Res. 2018 May 10;7:566
pubmed: 31240097
Environ Health Prev Med. 2020 Nov 3;25(1):66
pubmed: 33143660
Ann Intern Med. 2020 Jul 21;173(2):120-136
pubmed: 32369541